S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN COMBINATION WITH DARATUMUMAB

• N. W. van de Donk,
• N. Bahlis,
• M.-V. Mateos,
• K. Weisel,
• B. Dholaria,
• A. L. Garfall,
• H. Goldschmidt,
• T. G. Martin,
• D. Morillo,
• D. E. Reece,
• D. Hurd,
• P. Rodríguez-Otero,
• M. Bhutani,
• A. D’Souza,
• A. Oriol,
• E. Askari,
• J. F. San-Miguel,
• K. M. Kortüm,
• D. Vishwamitra,
• S. Xin Wang Lin,
• T. J. Prior,
• L. Vandenberk,
• M.-A. D. Smit,
• J. D. Goldberg,
• R. Wäsch,
• A. Chari

Affiliations

N. W. van de Donk

1 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

N. Bahlis

2 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada

M.-V. Mateos

3 University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

K. Weisel

4 University Medical Center Hamburg-Eppendorf, Hamburg, Germany

B. Dholaria

5 Vanderbilt University Medical Center, Nashville, TN

A. L. Garfall

6 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America

H. Goldschmidt

7 University Hospital Heidelberg, Internal Medicine and National Center for Tumor Diseases, Heidelberg, Germany

T. G. Martin

8 University of California, San Francisco, San Francisco, CA, United States of America

D. Morillo

9 Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

D. E. Reece

10 Princess Margaret Cancer Centre, Toronto, ON, Canada

D. Hurd

11 Section on Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC, United States of America

P. Rodríguez-Otero

12 Clínica Universidad de Navarra, Navarra, Spain

M. Bhutani

13 Levine Cancer Institute/Atrium Health, Charlotte, NC

A. D’Souza

14 Medical College of Wisconsin, Milwaukee, WI, United States of America

A. Oriol

15 Institut Català d’Oncologia and Institut Josep Carreras and Hospital Germans Trias i Pujol, Badalona, Barcelona

E. Askari

16 Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid

J. F. San-Miguel

17 Clínica Universidad de Navarra, CCUN, CIMA, CIBERONC, IDISNA, Pamplona, Spain

K. M. Kortüm

18 Medizinische Klinik II, Universitätsklinikum Würzburg, Würzburg, Germany

D. Vishwamitra

19 Janssen Research & Development, Spring House, PA, United States of America

S. Xin Wang Lin

19 Janssen Research & Development, Spring House, PA, United States of America

T. J. Prior

19 Janssen Research & Development, Spring House, PA, United States of America

L. Vandenberk

20 Janssen Research & Development, Beerse, Belgium

M.-A. D. Smit

21 Janssen Research & Development, Los Angeles, CA

J. D. Goldberg

22 Janssen Research & Development, Raritan, NJ, United States of America

R. Wäsch

23 University of Freiburg, Freiburg, Germany

A. Chari

24 Mount Sinai School of Medicine, New York, NY, United States of America